Grace Therapeutics (GRCE) Revenue (2012 - 2026)
Grace Therapeutics (GRCE) posted Revenue of $141,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 30.9% from $204,000 a year earlier but up 2.2% from the prior quarter.
Grace Therapeutics (GRCE) Revenue (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Grace Therapeutics was $623,000, down 10.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $685,000, down 5.9% from FY2025.
- Annual Revenue shows a five-year compound annual growth rate of 28.4% (FY2021 to FY2026).
- In prior fiscal years, Grace Therapeutics' Revenue was $728,000 in FY2025 (-16.8%) and $875,000 in FY2024.
- Quarterly Revenue has run from a low of $127,000 in fiscal Q3 2025 to a high of $235,000 in fiscal Q1 2025 over five years.
- On a year-over-year basis, Revenue increased in 1 of the last five quarters, with an average decline of 7.8%.
- According to Business Quant data, Revenue for the three prior fiscal quarters was $138,000 (Q4 2026), $172,000 (Q3 2026) and $172,000 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | 154,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141,000.00 |
| Mar 31, 2026 | 138,000.00 |
| Dec 31, 2025 | 172,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 127,000.00 |
| Sep 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2021 | 115,000.00 |
| Dec 31, 2020 | 81,000.00 |
| Mar 31, 2018 | 1.17 Mn |
| Dec 31, 2017 | -960,313.54 |
| Sep 30, 2017 | -116,421.33 |
| Nov 30, 2016 | 1.26 Mn |
| Aug 31, 2016 | 3,651.00 |
| May 31, 2016 | 2,888.00 |
| Nov 30, 2015 | 5,074.00 |
| Aug 31, 2015 | 6,999.00 |
| May 31, 2015 | 5,154.00 |
Grace Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();